Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Lavender Bina Cendikia Tbk. (BMBL) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance

Lavender Bina Cendikia Tbk.Trade
Diagnos Laboratorium Utama Tbk.Trade

Price performance (Past 24H)

Key statistics

Lavender Bina Cendikia Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Lavender Bina Cendikia Tbk. trades at Rp31 (market cap 32.96B, 2.08M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp230 (market cap 319B, 50.8K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 9.7× Lavender Bina Cendikia Tbk.'s market cap, and Lavender Bina Cendikia Tbk. is more actively traded (2.08M versus 50.8K). Which is the better fit depends on your goals.

BMBLDGNS
Market Cap
32.96B319B
Volume
2.08M50.8K
Lot
20.76K508
Turnover
63.4M11.61M
Average Price
30.54228.47
Value
63.4M11.61M
Indicative Equilibrium Price
232
Indicative Equilibrium Volume
200

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BMBL
View details
DGNS
View details

About Lavender Bina Cendikia Tbk.

PT Lavender Bina Cendikia Tbk ("Company") was established on November 27, 2013 based on theNotarial deed of Suparman Hasyim, S.H., No. 35. The Company started its commercial operations in2013. The ultimate beneficial owner of the Company is Galih Pandekar.

Read more on BMBL

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS